Both the NLRP3 inflammasome and IL-33/ST2 pathways appear to aggravate the inflammatory responses in LN, and HNK significantly suppresses the activation of the NLRP3/IL-33/ST2 axis in LN patients (Fig. 8). The gene discussed is IL33; the disease is lobular neoplasia.